RxDoctor Payments Data

Alejandro Figueroa Navarro

Cardiovascular Disease · Caguas, PRNPI 1053693283

Payments from drug & device makers

$7,257in general payments, 2019–2025

Across 270 payments — averaging $26.88 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Abbott$4K
  • Medtronic$850
  • ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$738
  • Boston Scientific$592
  • AstraZeneca$448
  • Johnson & Johnson$223
  • plus $702 from 9 others

What the payments were for

  • Travel & lodging$1,79825%
  • Food & beverage$5,45975%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$7,257 in reported general payments places this provider in the 75th percentile of 267 cardiovascular disease providers in Puerto Rico.

See all cardiovascular disease providers in Puerto Rico

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban193$128,575
EntrestoSacubitril/Valsartan158$121,548
XareltoRivaroxaban189$116,077
Repatha SureclickEvolocumab120$68,422
JardianceEmpagliflozin43$32,498
BrilintaTicagrelor53$27,184
Metoprolol Succinate1,110$11,709
FarxigaDapagliflozin Propanediol14$11,658
SynjardyEmpagliflozin/Metformin Hcl15$9,269
Atorvastatin Calcium1,118$8,744
Losartan Potassium877$7,444
JanumetSitagliptin Phos/Metformin Hcl13$6,589
SynthroidLevothyroxine Sodium102$6,088
Candesartan Cilexetil81$4,892
ClopidogrelClopidogrel Bisulfate593$4,726

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
NovartisEntresto$47$121,548158 claims
Johnson & JohnsonXarelto$223$116,077189 claims
Boehringer IngelheimJardiance, Synjardy$136$41,76758 claims
AstraZenecaBrilinta, Farxiga$448$38,84267 claims
MerckJanumet$106$6,58913 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 267 cardiovascular disease providers in Puerto Rico.

Other cardiovascular disease in Caguas

See the full list for Puerto Rico

Where these figures come from

Is this you, or does something look wrong? →